The incremental cost effectiveness of withdrawing pulmonary artery catheters from routine use in critical care

Applied Health Economics and Health Policy

Volumn 4, Issue 4, 2005, Pages 257-264

  Stevens, Katherine ^a   McCabe, Christopher ^a   Jones, Carys ^b   Ashcroft, Joanne ^b   Harvey, Sheila ^b   Rowan, Kathy ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b and London School of Hygiene Tropical Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ECONOMIC ASPECT; EVALUATION; HEALTH SURVEY; HUMAN; INTENSIVE CARE; METHODOLOGY; MORTALITY; OUTCOME ASSESSMENT; PATIENT; PULMONARY ARTERY CATHETER; UNITED KINGDOM;

AGED; CATHETERIZATION, SWAN-GANZ; COST-BENEFIT ANALYSIS; FEMALE; GREAT BRITAIN; HOSPITAL COSTS; HOSPITAL MORTALITY; HOSPITALS, PUBLIC; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MODELS, ECONOMETRIC; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; QUALITY-ADJUSTED LIFE YEARS; RISK ASSESSMENT; STATE MEDICINE; WITHHOLDING TREATMENT;

EID: 32644437503     PISSN: 11755652     EISSN: 11755652     Source Type: Journal    
DOI: 10.2165/00148365-200504040-00008     Document Type: Article

References (36)

1. Guyatt G. A randomized control trial of right-heart catheterization in critically ill patients: Ontario Intensive Care Study Group. J Intensive Care Med 1991; 6 (2): 91-5
2. Rhodes A, Cusack RJ, Newman PJ, et al. A randomised, controlled trial of the pulmonary artery catheter in critically ill patients. Intensive Care Med 2002; 28 (3): 256-64
3. Richard C, Warszawski J, Anguel N, et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003; 290 (20): 2713-20
4. Isaacson IJ, Lowdon JD, Berry AJ, et al. The value of pulmonary artery catheter and central venous monitoring in patients undergoing abdominal aortic reconstructive surgery: a comparative study of two selected, randomized groups. J Vasc Surg 1990; 12 (6): 754-60
5. Joyce W, Provan JL, Ameli FM, et al. The role of central haemodynamic monitoring in abdominal aortic surgery: a prospective randomised study. Eur J Vasc Surg 1990; 4 (6): 633-6
6. Pearson KS, Gomez MN, Moyers JR, et al. A cost/benefit analysis of randomized invasive monitoring for patients undergoing cardiac surgery. Anesth Analg 1989; 69 (3): 336-41
7. Bender JS, Smith-Meek MA, Jones CE. Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery. Ann Surg 1997; 226 (3): 229-37
8. Berlauk JF, Abrams JH, Gilmour IJ, et al. Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery: a prospective, randomized clinical trial. Ann Surg 1991; 214 (3): 289-99
9. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348 (1): 5-14
10. Shoemaker WC, Appel PL, Kram HB, et al. Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94: 1176-86
11. Valentine RJ, Duke ML, Inman MH, et al. Effectiveness of pulmonary artery catheters in aortic surgery: a randomized trial. J Vasc Surg 1998; 27: 203-12
12. Connors Jr AF, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 1996 Sep; 276: 889-97
13. Pulmonary Artery Catheter Consensus Conference Participants. Consensus statement. Pulmonary Artery Catheter Conference. Crit Care Med 1997; 25: 910-25
14. Dalen JE, Bone RC. Is it time to pull the pulmonary artery catheter? JAMA 1996; 276 (6): 916-8
15. Soni N. Swan song for the San-Ganz catheter? The use of pulmonary artery catheters probably needs re-evaluation: but should they be banned? BMJ 1996; 313: 763-4
16. Reinhart K, Radermacher P, Sprung CL, et al. PA catheterization: quo vadis? Do we have to change the current practice with this monitoring device? Intensive Care Med 1997; 23: 605-9
17. Weinstein MC. Should physicians be gatekeepers of medical resources? J Med Ethics 2001; 27: 268-74
18. Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005; 366: 472-7
19. Drummond MF, O'Brien B, Stoddart G, et al. Methods for the economic evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
20. Tarn TYH, Smith MD. Pharmacoeconomic guidelines around the world. ISPOR Connections 2004; 10 (4): 5-15
21. National Institute for Clinical Excellence (NICE). Guide to the methods of technology appraisal [online]. Available from URL: http://www.nice.org.uk/ page.aspx?.o = 201974 [Accessed 2005 Jul 26]
22. NHS reference costs. Department of Health [online]. Available from URL: http://www.dh.gov.uk/PolicyAndGuidance/OrganisationPolicy/FinanceAndPlanning/ NHSReferenceCosts/fs/en [Accessed 2004 Sep 1]
23. The Office for National Statistics [online]. Available from URL: http://www.gad.gov.uk/Life_Tables/Interim_Life_Tables.htm [Accessed 2005 Dec 20]
24. Kind P, Hardman G, Macran S. UK population norms for EQ-5D. CHE discussion paper no.: 172. York: The University of York; 1999 Nov
25. Wright JC, Penderleith L, Ridley SA. Long term survival following intensive care: sub-group analysis and comparison with the general population. Anaesthesia 2003; 58: 637-42
26. HM Treasury. The green book. London: HM Treasury, 2003 [online]. Available from URL: http://greenbook.treasury.gov.uk/ [Accessed 2004 Sep 14]
27. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996
28. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost effectiveness ratios: an example from a randomised trial. Stat Med 1996; 14: 1447-58
29. Efron B, Tisbshirani R J. An introduction to the bootstrap. New York: Chapman and Hall, 1993
30. Briggs A, Fenn P. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. Health Econ 1998; 7: 723-40
31. Van Hout BA, Al MJ, Gordon GS, et al. Costs, effects and C/E ratios alongside a clinical trial. Health Econ 1994; 3: 309-19
32. McCabe CJ, Payne JN, Pickin DM, et al. For NHS centre reviews and dissemination. Cholesterol and coronary heart disease: screening and treatment. Eff Health Care 1998; 4 (1): 1-16
33. Niskanen M, Kari A, Haonen P. Five-year survival after intensive care: comparison of 12,180 patients with the general population. Crit Care Med 1996 Dec; 24 (12): 1962-7
34. Palmer S, Smith PC. Incorporating options values into the economic evaluation of healthcare technologies. J Health Econ 2000; 19: 755-66
35. Briggs AH, O'Brien BJ. The death of cost minimization analysis. Health Econ 2001; 10: 179-84
36. Claxton C, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002; 360: 711-5